Literature DB >> 31023084

Elevated levels of circulating microvesicles in coronary artery disease patients with type 2 diabetes and albuminuria: Effects of exercise training.

Vibeke Bratseth1,2, Gemma Chiva-Blanch3, Rune Byrkjeland1, Svein Solheim1, Harald Arnesen1,2, Ingebjørg Seljeflot1,2.   

Abstract

OBJECTIVE: Circulating microvesicles, released from activated/apoptotic cells, are involved in vascular complications and may be looked upon as biomarkers. Albuminuria is characteristic of disease progression in type 2 diabetes mellitus. We aimed to investigate quantitative and qualitative differences of circulating microvesicles in type 2 diabetes mellitus with and without albuminuria and whether 12-month exercise training influenced expression of circulating microvesicles.
METHODS: Coronary artery disease patients with type 2 diabetes mellitus (n = 75), of which 25 had albuminuria, were included. Annexin V+ (AV+) circulating microvesicles were analysed by flow cytometry in citrated plasma. The exercise volume was 150 min per week.
RESULTS: In albuminuria patients, circulating microvesicles from endothelial-(CD146+/CD62E+/AV+) and endothelial-progenitor-(CD309+/CD34+/AV+) cells were significantly higher compared to those without (p ⩽ 0.01, both). Receiver operating characteristic curve analysis of the endothelial circulating microvesicles shows an area under the curve of 0.704 (95% confidence interval: 0.57-0.84; p = 0.004). Albuminuria patients had more circulating microvesicles derived from activated leukocytes and monocytes and monocytes carrying tissue factor (CD11b+/AV+, CD11b+/CD14+/AV+, CD142+/CD14+/AV+, respectively, p ⩽ 0.05, all) and higher number of circulating microvesicles from activated platelets (CD62P+/AV+). Within exercising patients, circulating microvesicles from progenitor cells increased (p = 0.023), however, not significantly different from controls.
CONCLUSION: Coronary artery disease patients with type 2 diabetes mellitus and albuminuria had elevated number of circulating microvesicles from activated blood and vascular cells, rendering them as potential predictors of disease severity. The circulating microvesicles were limitedly affected by long-term exercise training in our population.

Entities:  

Keywords:  Albuminuria; exercise training; flow cytometry; microvesicles and type 2 diabetes mellitus

Year:  2019        PMID: 31023084     DOI: 10.1177/1479164119843094

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  5 in total

Review 1.  Effects of Exercise on Extracellular Vesicles in Patients with Metabolic Dysfunction: a Systematic Review.

Authors:  Tong Li; Xiaowan Han; Shiqi Chen; Baofu Wang; Yu Teng; Weiting Cheng; Ziwen Lu; Yang Li; Xiaoxiao Wu; Yangyang Jiang; Lei Wang; Lisong Liu; Mingjing Zhao
Journal:  J Cardiovasc Transl Res       Date:  2022-06-02       Impact factor: 4.132

Review 2.  Platelets at the Crossroads of Pro-Inflammatory and Resolution Pathways during Inflammation.

Authors:  Nadine Ludwig; Annika Hilger; Alexander Zarbock; Jan Rossaint
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

3.  Annexin V+ Microvesicles in Children and Adolescents with Type 1 Diabetes: A Prospective Cohort Study.

Authors:  Vibeke Bratseth; Hanna D Margeirsdottir; Gemma Chiva-Blanch; Martin Heier; Svein Solheim; Harald Arnesen; Knut Dahl-Jørgensen; Ingebjørg Seljeflot
Journal:  J Diabetes Res       Date:  2020-03-30       Impact factor: 4.011

4.  Endothelial Microparticles as Potential Biomarkers in the Assessment of Endothelial Dysfunction in Hypercholesterolemia.

Authors:  Nik Nor Izah Nik Ibrahim; Razlina Abdul Rahman; Maryam Azlan; Aniza Abd Aziz; Aida Hanum Ghulam Rasool
Journal:  Medicina (Kaunas)       Date:  2022-06-19       Impact factor: 2.948

Review 5.  Exploring New Kingdoms: The Role of Extracellular Vesicles in Oxi-Inflamm-Aging Related to Cardiorenal Syndrome.

Authors:  Cristina Mas-Bargues; Matilde Alique; María Teresa Barrús-Ortiz; Consuelo Borrás; Raquel Rodrigues-Díez
Journal:  Antioxidants (Basel)       Date:  2021-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.